why choose us

First received: October 31, 2022

Clinical Trial: Omega-3 Supplementation on Serum Fetuin-A Levels

Study Status: Completed

Recruit Status: Completed

Condition: Coronary Artery Disease

Study Type: Interventional


Official Title: Effects of Omega-3 Fatty Acid Supplementation on Serum Fetuin-A Levels in Patients With Coronary Artery Disease

Brief Summary: Background and aims: One of the investigated possible modulators of serum fetuin-A, associated with the risk of developing coronary artery disease (CAD), is omega-3 fatty acids (FAs). This study aims to evaluate the effects of omega-3 FA supplementation on serum fetuin-A concentration in patients with CAD.Methods: The study was carried out on 34 male volunteer patients aged 35-75 years, newly diagnosed with CAD by conventional coronary angiography. Patients with CAD were divided into the "Omega-3 Group (n:16)" and…

Read more